Filter
277
Filtered Results: 277
Text search:
FDA
US
Food
&
Drug
Administration
Featured
Recommendations
27
New Publications
64
Language
Document type
No document type
158
Guidelines
53
Studies & Reports
38
Manuals
12
Fact sheets
8
Training Material
2
Resource Platforms
2
Strategic & Response Plan
2
Brochures
1
Situation Updates
1
Countries / Regions
India
12
Myanmar / Burma
8
Philippines
7
USA
7
Russia
7
Ghana
5
Western and Central Europe
5
Uganda
4
South Sudan
4
Thailand
3
Syria
3
Nigeria
3
Latin America and the Carribbean
3
Germany
3
Congo, Democratic Republic of
3
Middle East and North Africa
3
Nepal
2
Rwanda
2
Africa
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Bangladesh
2
South Africa
2
Eastern Europe
2
Yemen
2
Angola
2
Tajikistan
1
Sierra Leone
1
Singapore
1
Senegal
1
Peru
1
Mozambique
1
Global
1
Haiti
1
Cambodia
1
Asia
1
Guinea-Bissau
1
Venezuela
1
Jordan
1
Paraguay
1
Argentina
1
Brazil
1
Namibia
1
Sudan
1
Botswana
1
Indonesia
1
Iraq
1
Liberia
1
Authors & Publishers
Publication Years
Category
COVID-19
17
Guidelines
15
HIV & STI
12
Hepatitis
11
Policies & Guidelines HIV & TB
11
TB
10
Drugs & Medical Equipment
9
Policies
8
Pediatrics
5
Diabetes
4
Studies & Reports
4
Capacity Building
4
Reproductive Health
4
Virology
3
Gynaecology & Obstetrics
3
Pharmacy & Technologies
3
Cancer Treatment & Resources
2
Countries
2
Chagas
2
Women & Child Health
2
Community Health
2
Laboratory Quality Assurance
2
Age & Elderly
2
Malaria
2
Communicable Diseases
1
Dental & Eye Care
1
Paediatrics
1
Clinical Training
1
Family Planning
1
Pharmacy & Technology
1
Buruli Ulcer
1
Disaster Preparedness
1
Bacteriology
1
Cancer
1
Vector Control
1
Cervical Cancer
1
MPOX - Monkeypox
1
Water, Sanitation and Hygiene (WASH)
1
Infection Control & Prevention (IPC)
1
Vaccine-preventable Diseases
1
Pharmaceutical Assessments
1
Cardiovascular Diseases
1
Hemorrhagic Fever
1
Diarrhoeal Disease/Cholera
1
Clinical Guidelines
1
Diarrhoea
1
General Guidelines
1
Communicable Diseases
1
Maternal Health
1
Parasitology
1
Water
1
Neonatal Care
1
Disease Prevention & Control
1
Key Resources
1
Toolboxes
Children/Adolescents Mental Disorders
15
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
12
Drug resistant TB
11
Studies
7
Diagnostics & Laboratory Guidance
7
Country specific documents
7
Clinical Aspects, Treatment & Prevention
6
Antiretroviral Treatment ART
6
Country specific
5
PPE Personel Protective Equipment
5
Infection Control General
5
Substance Use Disorders & Addiction
5
HIV testing & services
4
Adults
4
Research
4
Clinical Guidelines
4
Detection & Diagnosis
4
others
4
Bipolar Affective Disorders
4
Depression
4
Treatment & Prevention
3
Hepatitis
3
General
3
SARS-CoV-2 Variants
3
Essential Medicines
3
Pharmacy Practice
3
Rational use of Medicine
3
Pharmacovigilance
3
Antimicrobial Resistance (AMR)
3
Alzheimer's Disease & Dementia
3
TB & Prisoners
3
Testing Guidelines
3
Preparedness & Prevention
3
ART Drug Resistance
2
Children & Adolescents
2
Clinical Guidelines
2
Treatment Guidelines HIV
2
Public Health
2
Drug resistance
2
International
2
Treatment Guidelines
2
Supporting tools
2
For Health Worker
2
Blood Supply
2
Communication Material
2
Preparedness, Response & Risk Communication
2
Vaccine Hesitancy & Myths
2
Biontech/Pfizer Comirnaty
2
Prices and Patents
2
Falsified & Substandard
2
Supply Chain & Store Management
2
Quality Assurance
2
Reports & Studies
2
Mental Disorders
2
Chagas
2
Clinical Aspects & Diagnostics
2
Studies & Reports
2
Overview, Studies & Reports
2
Women
2
Neurological Disorders
2
Technical Information
2
Training
2
Research & Access
2
Technical Information
2
Roadmaps, Action Plans & Policies
2
Assessment
2
TB/HIV Coinfection
2
Tobacco
2
Clinical Guidelines
2
Anxiety Disorders
2
Lobby and Advocacy
2
Treatment Guidelines
1
Clinical Guidelines
1
Male Circumcision
1
General Reports
1
TB & Drug Abuse
1
Agriculture & Veterinary
1
Posttraumatic stress disorder Adults
1
Faith-based Organizations
1
Surveillance
1
Background PTSD in children
1
Chemical Attacks
1
Preparedness, Response & Risk Communication
1
Opportunistic Infections
1
Schizophrenia
1
Context, Facts & Travel Advice
1
Infection Control
1
Opoids
1
Curricula & Core Competencies
1
Drug resistance
1
TB
1
Preparedness, Response & Risk Communication
1
TB & Other Vulnerable Populations
1
Children
1
Training Supporting Material mhGAP
1
Attention deficit hyperactivity disorder (ADHD)
1
Laboratory & Sampling
1
Laboratory
1
Prevention & Preparedness
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Research & Development
1
Surveillance & Contact tracing
1
Clinical Guidelines
1
Scientific & Research Studies
1
Educational Settings
1
Workplace
1
Physical Distancing
1
Medical & Community Masks
1
Oxygen Therapy
1
Essential Medicines & Medical Devices
1
Hospital Readiness/Essential Health Services
1
Access & Strategy
1
Gambling
1
TB/HIV
1
Logistics & Supply
1
Fair Allocation & Ethical Aspects
1
Moderna
1
Johnson & Johnson
1
Research & Pipeline
1
Hygiene
1
Overview & reports
1
Pharmacy Management
1
Pharmaceutical Assessments
1
Waste Managment
1
Environment
1
Zoonoses
1
Nuclear & Chemical Hazards
1
MPOX - Monkeypox
1
MPOX -Monkeybox Prevention & Control
1
NTDs
1
Information & Education Material (IEC)
1
Studies & Reports
1
Studies & Reports
1
Awareness
1
Global Overview
1
Clinical Guidelines
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Co-Morbidities (except TB)
1
Ghana
1
General
1
Regional Reports & Guidelines, others
1
Human Rights & the Right to Health
1
Asia
1
Diarrhoea
1
Prevention of mother-to-child transmission (PMTCT)
1
Germany
1
Situation Reports & Updates
1
Technical Information
1
Vision Loss & Blindness
1
Zika Prevention & Control
1
Others
1
Tajikistan
1
WASH
1
AmR (Region of Americas)
1
TB
1
Preparedness & Prevention
1
IEC Material Neurological Disorders
1
Eastern Europe & Central Asia
1
Laboratory & Diagnostics
1
AMR
1
Reports & Studies
1
Global Health Ethics
1
Handbook of Foodborne Pathogenic Microorganisms and Natural Toxins
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of products granted marketing authorization in Ghana.
A survival guide for clinicans.
3rd edition.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
FEY ENFOMASYON POU MOUN K’AP RESEVWA AVEK MOUN K’AP BAY SWEN OTORIZASYON POU ITILIZASYON IJANS (EUA) POU VAKSIN MODERNA COVID-19 POU ANPECHE CORONAVIRUSDISEASE 2019
(COVID-19) NAN PERSONN 18 ANE AK PI GRAN
English Manual and Guideline on World about Food and Nutrition, Health and Epidemic; published on 30 Nov 2021 by USAID
Three Years After Enactment of the Drug Quality and Security Act
FDA’s compounding program aims to protect patients from unsafe, ineffective and poor quality compounded drugs, while preserving access to lawfully-marketed compounded drugs for patients who have a medical need for them. Here you can find informations to laws &policies, compliance action, ....
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
